Bemesetron
CAS No. 40796-97-2
Bemesetron ( MDL 72222; 3-TROPANYL-3,5-DICHLOROBENZOATE; TROPANYL 3,5-DICHLOROBENZOATE )
产品货号. M26626 CAS No. 40796-97-2
Bemesetron is a selective antagonist of 5-HT3 (IC50 = 0.33 nM) with neuroprotective effects.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
10MG | ¥405 | 有现货 |
|
25MG | ¥518 | 有现货 |
|
50MG | ¥697 | 有现货 |
|
100MG | 获取报价 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Bemesetron
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Bemesetron is a selective antagonist of 5-HT3 (IC50 = 0.33 nM) with neuroprotective effects.
-
产品描述Bemesetron is a selective antagonist of 5-HT3 (IC50 = 0.33 nM) with neuroprotective effects.(In Vitro):In primary cortical neuronal cells, Bemesetron (1 μM) significantly blocks the H2O2-induced increase of caspase-3 immunoreactivity. Bemesetron (0.01, 0.1 and 1 μM) and Y25130 (0.05, 0.5 and 5 μM) concentration-dependently reduce the H2O2-induced decrease showing inhibition of 74.9 and 79.0% with 1 μM and 5 μM, respectively.(In Vivo):In male adult albino mice, Bemesetron (1 mg/kg; i.p.) causes a significant reduction of catalepsy, while Bemesetron (10 mg/kg; i.p.) significantly potentiates the phenomenon. The maximum inhibition of catalepsy (about 75%) occurs at 120 min, and the maximum potentiation (about 4.5-times the control value) occurs at 60 min after Haloperidol.
-
同义词MDL 72222; 3-TROPANYL-3,5-DICHLOROBENZOATE; TROPANYL 3,5-DICHLOROBENZOATE
-
通路Endocrinology/Hormones
-
靶点5-HT Receptor
-
受体NLRP3
-
研究领域——
-
适应症——
化学信息
-
CAS Number40796-97-2
-
分子量314.2
-
分子式C15H17Cl2NO2
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESCN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)c1cc(Cl)cc(Cl)c1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Ruan S, et al. Antcin A alleviates pyroptosis and inflammatory response in Kupffercells of non-alcoholic fatty liver disease by targeting NLRP3. Int Immunopharmacol. 2021 Nov;100:108126.
产品手册
关联产品
-
Minaprine
Minaprine is a psychotropic drug which has proved to be effective in the treatment of various depressive states.
-
Eplivanserin
Eplivanserin is an effective and selective antagonist of 5-HT2A receptor with a Kd of 1.14 nM and an IC50 value of 5.8 nM in rat cortical membrane.
-
Landipirdine
A novel 5-HT receptor antagonist for the treatment of Parkinson's disease.